0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Review |  ONLINE FIRST
Zofia Piotrowska, MD; Lecia V. Sequist, MD, MPH
JAMA Oncol. Published online May 19, 2016. doi:10.1001/jamaoncol.2016.0333

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge |  ONLINE FIRST
Paras Vakharia, PharmD; Yoshihiro Yonekawa, MD; Sandeep Randhawa, MD
JAMA Ophthalmol. Published online May 19, 2016. doi:10.1001/jamaophthalmol.2015.5359

JAMA | 
Editorial |  FREE ONLINE FIRST
Michael K. Gould, MD, MS
JAMA. Published online May 15, 2016. doi:10.1001/jama.2016.5986

JAMA | 
Original Investigation |  FREE ONLINE FIRST
Hormuzd A. Katki, PhD; Stephanie A. Kovalchik, PhD; Christine D. Berg, MD; et al.
JAMA. Published online May 15, 2016. doi:10.1001/jama.2016.6255
Includes: Supplemental Content

JAMA Ophthalmology | 
Ophthalmic Images |  ONLINE ONLY
Michael A. Klufas, MD; Colin A. McCannel, MD; Tara A. McCannel, MD, PhD
JAMA Ophthalmol. 2016;134(5):e155368. doi:10.1001/jamaophthalmol.2015.5368.

JAMA Oncology | 
Research Letter | 
Phillip M. Boiselle, MD; Caroline Chiles, MD; James G. Ravenel, MD; et al.
JAMA Oncol. 2016;2(5):682-684. doi:10.1001/jamaoncol.2015.6419.

JAMA Oncology | 
Viewpoint | 
Nathan A. Pennell, MD, PhD
JAMA Oncol. 2016;2(5):569-570. doi:10.1001/jamaoncol.2016.0040.

JAMA Oncology | 
Viewpoint | 
Aaron Lisberg, MD; Edward B. Garon, MD
JAMA Oncol. 2016;2(5):571-572. doi:10.1001/jamaoncol.2016.0043.

JAMA Oncology | 
From The JAMA Network |  ONLINE FIRST
Joan M. Teno, MD, MS; J. Randall Curtis, MD, MPH
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0441

JAMA Oncology | 
Review |  ONLINE FIRST
Kevin Wood, MD; Thomas Hensing, MD; Raeva Malik, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0405
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
JAMA Ophthalmology Clinical Challenge  | 
Management of Retinal Whitening With Vitritis
Paras Vakharia, PharmD; Yoshihiro Yonekawa, MD; Sandeep Randhawa, MD
JAMA Oncology
Review  | 
Treatment of EGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors  A Review
Zofia Piotrowska, MD; Lecia V. Sequist, MD, MPH
JAMA
Editorial  | 
Who Should Be Screened for Lung Cancer? And Who Gets to Decide?
Michael K. Gould, MD, MS
JAMA
Original Investigation  | 
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Hormuzd A. Katki, PhD; Stephanie A. Kovalchik, PhD; Christine D. Berg, MD; et al.